4551 — Torii Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥104bn
- ¥60bn
- ¥55bn
- 68
- 59
- 67
- 76
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 37,700 | 4,225 | 4,767 | 5,722 | 5,593 |
Depreciation | |||||
Non-Cash Items | -36,231 | 470 | -232 | -312 | -365 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 40,045 | -8,721 | -5,105 | -3,444 | -8,811 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 42,499 | -3,444 | -157 | 2,420 | -3,124 |
Capital Expenditures | -546 | -411 | -374 | -281 | -216 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 2,645 | 8,036 | -1,124 | -13,395 | -3,563 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 2,099 | 7,625 | -1,498 | -13,676 | -3,779 |
Financing Cash Flow Items | — | -1 | — | -2 | -2 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1,433 | -1,425 | -1,546 | -1,698 | -3,835 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 43,165 | 2,756 | -3,201 | -12,954 | -10,738 |